Moderna Inc (MRNA) Company Profile & Statistics

Moderna Inc
MRNA
(Nasdaq - US)
Open
38.25
+1.31 (+3.55%)
in:usd•As of: Nov 21, 2024 13:40 UTC -5
Open
36.55
High
38.81
Low
35.98

About Moderna Inc

CEO

Stephane Bancel

Headquarters

200 technology square

cambridge, ma 02139, united states

Auditor

Ernst & Young LLP

Employees

5,600

Share Holders

Website

www.modernatx.com

Industry

biotechnology

Sector

health technology

Company Overview

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency use in several countries as COVID-19 vaccine. The company has also developed booster doses of its COVID-19 vaccine and is developing variant-specific booster candidates.

Moderna Inc Statistics

Valuation Measures

Market Capitalization ²	14.72B
Enterprise Value	13.70B
Enterprise Value/EBITDA (ttm)	-5.57
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.20
Price to Sales (ttm)	2.82
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	58.54%
Operating Margin (ttm)	-43.77%
Profit Margin (ttm)	-306.47%
Return on Equity (ttm)	-17.68%
Return on Invested Capital (ttm)	-17.57%
Return on Assets (ttm)	-13.35%

Income Statement

Revenue (ttm)	5.08B
Revenue Per Share (ttm)	13.20
Gross Profit (ttm)	3.43B
EBITDA (ttm)³	-2.46B
Net Income Avi to Common (ttm)	-2.22B
Diluted EPS (ttm)	-5.82

Share Statistics

Beta (5Y Monthly)	1.69
52-Week Change	-51.56%
S&P500 52-Week Change	31.24%
S&P500 Member	Yes
Stock Optionable	Yes
Total Shares Outstanding ¹	384.82M
Dividend Yield	0.00%
Float ⁴	324.40M
% Held by Insiders	15.70%
% Held by Institutions	75.33%

Balance Sheet

Total Cash (mrq)	6.87B
Total Cash Per Share (mrq)	17.84
Total Debt (mrq)	625.00M
Total Debt/Equity (mrq)	5.24%
Current Ratio (mrq)	4.39%
Quick Ratio (mrq)	4.20%
Book Value Per Share (mrq)	30.98

Cash Flow

Operating Cash Flow Per Share (ytd)	-9.60
Free Cash Flow (ytd)	-4.36B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Moderna Inc

Trade With A Regulated Broker